Development and application of a computable genotype model in the GA4GH Variation Representation Specification

As the diversity of genomic variation data increases with our growing understanding of the role of variation in health and disease, it is critical to develop standards for precise inter-system exchange of these data for research and clinical applications. The Global Alliance for Genomics and Health (GA4GH) Variation Representation Specification (VRS) meets this need through a technical terminology and information model for disambiguating and concisely representing variation concepts. Here we discuss the recent Genotype model in VRS, which may be used to represent the allelic composition of a genetic locus. We demonstrate the use of the Genotype model and the constituent Haplotype model for the precise and interoperable representation of pharmacogenomic diplotypes, HGVS variants, and VCF records using VRS and discuss how this can be leveraged to enable interoperable exchange and search operations between assayed variation and genomic knowledgebases.

[1]  Matthew H. Brush,et al.  The GA4GH Variation Representation Specification: A computational framework for variation representation and federated identification , 2021, Cell genomics.

[2]  Grant M. Wood,et al.  GA4GH: International policies and standards for data sharing across genomic research and healthcare , 2021, Cell genomics.

[3]  John J. Connolly,et al.  Genomic considerations for FHIR®; eMERGE implementation lessons , 2021, J. Biomed. Informatics.

[4]  Alex H. Wagner,et al.  A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer , 2020, Nature Genetics.

[5]  Neil A. Miller,et al.  PharmVar and the Landscape of Pharmacogenetic Resources , 2019, Clinical pharmacology and therapeutics.

[6]  Lon Phan,et al.  SPDI: Data Model for Variants and Applications at NCBI , 2019, bioRxiv.

[7]  Aleksandar Milosavljevic,et al.  ClinGen Allele Registry links information about genetic variants , 2018, Human mutation.

[8]  Michelle Whirl-Carrillo,et al.  Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. , 2018, Pharmacogenomics.

[9]  S. Jackson,et al.  Haplotype-Based Genotyping in Polyploids , 2018, Front. Plant Sci..

[10]  T. Klein,et al.  New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine , 2017, Clinical pharmacology and therapeutics.

[11]  R. Durbin,et al.  Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly , 2016, bioRxiv.

[12]  Raymond Dalgleish,et al.  HGVS Recommendations for the Description of Sequence Variants: 2016 Update , 2016, Human mutation.

[13]  M Schwab,et al.  Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting , 2016, Clinical pharmacology and therapeutics.

[14]  Ulrich Broeckel,et al.  Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project. , 2016, The Journal of molecular diagnostics : JMD.

[15]  G. Escaramís,et al.  A decade of structural variants: description, history and methods to detect structural variation. , 2015, Briefings in functional genomics.

[16]  J. Fagerness,et al.  Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders , 2015, Genetics research.

[17]  Mario Pazzagli,et al.  Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe , 2015, Clinical chemistry and laboratory medicine.

[18]  K. Yamamoto,et al.  GLOBAL ALLIANCE FOR GENOMICS AND HEALTH , 2015 .

[19]  O. Gottesman,et al.  Implementation and utilization of genetic testing in personalized medicine , 2014, Pharmacogenomics and personalized medicine.

[20]  David S. Jones.  How Personalized Medicine Became Genetic, and Racial: Werner Kalow and the Formations of Pharmacogenetics , 2012, Journal of the history of medicine and allied sciences.

[21]  R. Altman,et al.  Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.

[22]  G. Kuo,et al.  Clinical Application of Pharmacogenomics , 2012, Journal of pharmacy and practice.

[23]  R. Verbrugge,et al.  Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey , 2012, Clinical pharmacology and therapeutics.

[24]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[25]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[26]  R. Altman,et al.  Databases in the area of pharmacogenetics , 2011, Human mutation.

[27]  T. Klein,et al.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network , 2011, Clinical pharmacology and therapeutics.

[28]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[29]  E. Lyon,et al.  Characterization of 107 Genomic DNA Reference Materials for CYP 2 D 6 , CYP 2 C 19 , CYP 2 C 9 , VKORC 1 , and UGT 1 A 1 A GeT-RM and Association for Molecular Pathology Collaborative Project , 2010 .

[30]  G. Kuo,et al.  Pharmacogenomics: bridging the gap between science and practice. , 2010, Journal of the American Pharmacists Association : JAPhA.

[31]  D. Flockhart,et al.  The Star‐Allele Nomenclature: Retooling for Translational Genomics , 2007, Clinical pharmacology and therapeutics.

[32]  Henk-Jan Guchelaar,et al.  Translating Pharmacogenomics: Challenges on the Road to the Clinic , 2007, PLoS medicine.

[33]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[34]  D W Nebert,et al.  Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. , 2000, Pharmacogenetics.

[35]  R. Angell,et al.  First-meiotic-division nondisjunction in human oocytes. , 1997, American journal of human genetics.

[36]  P. Frazier.  Bridging the Gap Between Science and Practice. , 1992 .